About

Gentle products, hard science, strong team

Determination. Dedication. Daring.

John Theroux
John Theroux
CEO & Director
John has served as head of the European practice of management consultants Bain and Company, as head of a number of early stage technology companies, and as senior lecturer at the Harvard Business School.
Bruce McConnell
Bruce McConnell
Head of Business Development
Bruce has served as the head of business development / innovation for several Nestlé businesses, on the Nestlé venture board and on the board of several health care start ups and JV’s.

Previously in business development for Sandoz Pharma and in consulting.
Helle Warrer Poulsen
Helle Warrer Poulsen
Chief Commercial Officer
Helle has served as the head of various commercial and innovation positions in industrial biotech for the past 12 years, latest as the VP for the Animal Health & Nutrition business division in Novozymes.

Prior to that Helle worked 6 years in Ramboll management consulting.
Jesper Mørk
Jesper Mørk
Chief Technology Officer
Jesper has served as head of Global Engineering at both Chr. Hansen and H. Lundbeck.

He also led the design and commissioning of the Biogen Idec facility in Denmark.

Jesper also served as Business and Process adviser at NNE Pharmaplan.
Kjeld Kjeldsen
Kjeld Kjeldsen
Site Director - Esbjerg
Kjeld has been working with biotechnological manufacturing for the last 12 years.

Kjeld has been leading the Esbjerg site the last 6 years. The site has a track record of continuous improvements.
Niels Banke
Niels Banke
Chief Science Officer
Niels has been working +25 years at Novo Nordisk and Novozymes in R&D, where he was head of fermentation process development in Denmark and brought over 100 strains from the lab into production.
Odd Erik Hansen
Odd Erik Hansen
Chief Operating Officer
Odd has supported several midsize and large food ingredient and biotech companies as an advisor in strategic and operational matters – working at McKinsey, Bain and Company, and as an independent.

He co-founded Bain’s Copenhagen Office.
Thomas Kabel
Thomas Kabel
Chief Financial Officer
Thomas has an M&A and finance background, and has helped biotech Novozymes grow through strategic acquisitions and partnership agreements.

Prior to this, Thomas was Vice President in the Danish investment bank, FIH Partners.
Our website uses cookies We will ask you to consent to our use of cookies in accordance with the terms of this policy read more
Ok